IDH2 inhibitors are used to treat acute myeloid leukemia (AML) and other specific forms of cancer. IDH2 inhibitors work by targeting and blocking mutated isocitrate dehydrogenase-2 (IDH2) enzymes, which helps to stop the growth of cancer cells. One example is an oral medication called Idhifa (enasidenib).